|
- 积分
- 80
- 威望
- 80
- 包包
- 167
|
回复 蒲公英 的帖子0 x( H2 ^6 @$ ]% _$ K0 t& l
/ B' t0 ^8 a' @" T# k6 o参考文献：
+ j7 A! u6 H. N1 Krampera M, Glennie S, Dyaon J，et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood, 2003;101:3722-37293 ~: @5 S4 ]0 ^9 T
2 Potian JA, Aviv H, Ponzio NM, et al. Vetolike activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol, 2003;171:3426-3434
% ?2 J& F- t: U$ z+ ~8 r5 G8 U3 Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci, 2005;12:47-57; X$ k$ T1 I t" G
+ W( P* ^5 g+ f. P, b# R9 C
4 DiNicola M, CarloStella C, Magni M, et al. Human bone marrow stromal cells suppress Tlymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002;99:3838-3843
3 ]. z& H3 u8 M8 g: x& w2 m- d! [3 ~# O# u; U' w0 s
5 Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitrogens and alloantigens by different mechanisms. Exp Cell Res, 2005; 305：33-41; S* d% y$ j( g9 K
1 Z( m4 k x' Q: |6 Sun S，Guo Z，Xiao X，et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cell, 2003;21:527-5350 @! j; N0 O% K7 F. Q
; L. p/ Q% a5 K. P
7 Maccario R, Podesta M, Moretta A, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigenspecific immune response favors the differentiation of CD4 Tcell subsets expressing a regulatory/suppressive phenotype. Haematologica, 2005;90:516-525" v# a% a! l; l& N
, [4 x' G8 ~) J: h5 M8 Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003;102: 3837-3844# P' Z2 m- Y' U7 r m; d3 y
' C9 G1 A, ?, ^. q+ a+ g& F
9 Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell response. Blood, 2005; 105:1815-1822
) U0 `& e8 y& N1 Y6 j7 m* Y6 j# F) W$ @+ o; m Y
10 Beyth S, Borovsk Z, Mevorach D，et al. Human mesenchymal stem cells alter antigen presenting cell maturation and induce Tcell unresponsiveness. Blood, 2005; 105:2214-2219
6 O- p h! q1 e. {) N, a7 z4 g; s5 b) C+ K
11 Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocytederived dentritic cells. Blood, 2005; 105; 4120-41269 ~. T* w N9 [% X" o @
+ ~: k. \" Y- ?) j7 b2 Z- O
12 Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34 derived and monocytederived dendritic cells. J Immunol, 2006; 177: 2080-2087% E5 y' w" o6 g+ \8 e: W5 s
" o0 Q! K4 d c! V" ~& b' W7 w. h
13 Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 2003; 76 :1208-1213
8 B& R8 m$ h) L; I
4 y7 t6 R% a" p) t14 Angoulvant D, Clerc A, Benchalal S, et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology, 2004; 41:469-476
( o# p5 _/ J7 U+ I N
0 }) {& B, i @9 Z" D$ U15 Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002; 30: 42-48' U* ]$ m/ n, |/ D0 g, V1 P
+ V/ r$ O! j# s/ A
16 Guo Z, Li H, Li X, et al. In vitro characteristics and in vivo immunosuppressive activity of compact bonederived murine mesenchymal progenitor cells. Stem Cells,2006; 24: 992-1000! U8 J/ h% Z) }, B5 A; o2 T
% y: n- Q# b$ }5 l2 I& }17 Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood, 2005; 106: 1755-1761
' q0 w# A# |& N2 F% m5 C) @# D: E! e6 Y C
18 Lazarus HM, Haynesworth SE, Gerson SL, et al. Ex vivo expansion and subsequent infusion of human bone marrowderived stromal progenitor cells (mesenchymal stem cells): implication for therapeutic use. Bone Marrow Transplant, 1995; 16: 557-564
: f N+ u+ J! r. @$ ~. q, ~+ Z3 n( h E* a! A) P! p
19 Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLAidentical sibling cultureexpanded mesenchymal stem cells and hematopioetic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005; 11:389-398
( `/ T2 T7 D0 b+ W. M+ \% p( E6 w2 E" s
20 Lee ST, Jang JH, Cheong JW, et al. Treatment of highrisk acute myelogenous leukemia by myeloablative chemoradiotherapy followed by coinfusion of T celldepleted haematopioetic stem cells and cultureexpanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol, 2002; 118:1128-1131
9 V8 E% H3 d: ]( k" k; L! C( g% H/ u$ J& Y
21 LeBlanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graftversushost disease with third party haploidentical mesenchymal stem cells. Lancet, 2004; 363(9419):1439-1411( O6 v; o E6 M* a+ L5 c1 s: ?+ r
|
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|
发表于 2013-3-25 12:36
大家帮忙看看，给点意见和建议哈~
我也只是列举了一小部分
发表于 2013-3-31 09:05
